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The  interaction  between cells in the early mammalian  embryo is an important 
part  of  differentiation.  This  interaction  has  been  the  topic  of  numerous 
investigations  which  have  increased  our  understanding  of how differentiation 
proceeds. Studies where whole embryos are fused (12,  19) provide one method by 
which the type of embryo cells interacting  can be partially  regulated.  Another 
method for controlling the cells that interact was first reported by Gardner (5, 6). 
In this technique  a  few cells from the inner  cell mass of one embryo are placed 
into another  blastocyst. Moustafa and  Brinster  (14,  15)  used this technique  to 
study  the  ability  of older  embryo  cells  to  participate  in  the  development  of 
blastocysts into which the older cells were placed. These studies indicated that 
cells as much as 4 days older than  the recipient blastocyst could participate  in 
development of the embryo. 
The ability of older and asynchronous cells to participate  in embryo develop- 
ment suggested the possibility that  cells taken from the adult animal might be 
capable of influencing  the development of the embryo. To test this possibility, 
two  types  of  nonembryonic  cells  were  placed  in  mouse  blastocysts  and  the 
blastocysts allowed to develop to term  in  a  foster mother.  The  cells employed 
were (a) bone marrow cells from CBA T6T6 mice and (b) teratocarcinoma  cells 
taken from ascites fluid of 129 SvS1 mice in which the tumor was propagated as 
an  intraperitoneal  tumor.  The  results  of these  studies  are  reported  here  and 
indicate  that  the  transferred  cells  did  affect  the  offspring  resulting  from  the 
blastocysts that received the donor cells. 
Methods  and  Materials 
Obtaining and Handling Blastocysts.  The mouse blastocysts were obtained by superovulating 
random-bred  Swiss  albino  females  with  gonadotrophins  (3,  4).  On  the  4th  day  after  mating, 
blastocysts were collected by flushing the uterus with culture  medium. The medium was Eagle's 
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basal  medium supplemented with 5  ×  10 -* M  pyruvate and  10% fetal calf serum (EBMS)J The 
blastocysts from several females were pooled, washed three times, and stored in medium at 37°C 
under an atmosphere of 5% COs in air (4).  These blastocysts were the recipients for the transferred 
cells. 
Obtaining and Handling  Cells.  The bone marrow cells were obtained by flushing the femur of 
adult CBA T6T6 animals with culture medium. The cell suspension was examined and individual cells 
selected for transfer. An attempt was made to select cells which had characteristics similar to stem 
cells. The characteristics used were those suggested by van Bekkum et al. (20) and Haskill and Moore 
(8).  These cells were round, approximately 8-10 ~ in diameter, and appeared to have a large nucleus 
with one or two nucleoli. However, a positive identification as stem cells was not possible. 
Cells from mouse testicular teratocarcinoma OTT 6050 (17) were from ascitic fluid which develops 
in  129  SvS1  mice after they have received an  intraperitoneal injection of ascitic fluid containing 
teratoma cells (18).  In the ascitic fluid are  found tumor masses which morphologically resemble 
normal mouse embryos of the late morula and early blastocyst stage. These masses have ectoderm 
enveloped in a  layer of endoderm (18).  The embryoid masses were placed in phosphate-buffered 
saline containing 0.25% trypsin and separated into individual cells by pipetting them back and forth 
in a narrow pipette. The cells were placed in Eagle's basal medium with 10% fetal calf serum. 
Blastocyst Manipulation.  The apparatus used to make the cell transfers consists of right and left 
handed Leitz micromanipulators and a Leitz Laborlux II microscope (E. Leitz, Rockleigh, N. J.). The 
blastocysts were placed in the well of a cavity slide containing 100 #l of the culture medium (EBMS 
with the NaHCO3 replaced by Hepes) and covered by liquid silicone. The left hand micromanipulator 
holds a blunt suction pipette (the inside diameter is 5 #  and the outside diameter is 100 #) and the 
right hand micromanipulator holds the injection pipette. The diameter of the injection pipette is 
varied to just accommodate the type cell to be injected. The pipette should have a thin wall and a 
tapered tip. The blastocysts and cells are placed in the well of the cavity slide, and the blastocyst 
picked up  on  the end of the suction pipette.  The  cells are picked up  with the injection pipette 
(previously filled with oil) and the pipette inserted through the zona pellucida and blastocoele wall 
into  the  cavity.  2-4  cells  are  placed  near  or  against  the  inner  cell  mass.  The  pipette is  slowly 
withdrawn to prevent the escape of the cells. The injected or recipient blastocyst is then removed 
from  the slide and placed in  a  watch glass containing culture  medium until transfer to a  foster 
mother. 
Transferring  Blastocysts  to  Foster  Mothers.  The  foster  mothers  are  obtained  by  injecting 
random-bred Swiss albino females with 2  U  of pregnant mares serum  followed in  48  h  with an 
injection of 2 U of human chorionic gonadotrophin. The females are placed with vasectomized males 
who have been proven sterile, The injections for the foster mothers are begun 24 h after those for the 
females producing the recipient blastocysts. The foster mothers are anesthetized with pentabarbitol 
and the hair clipped from a 3 cm square area over the area of the ovary. A 1-cm incision is made in the 
skin and abdominal wall over the ovary and the ovarian fat pad, ovary, and uterus withdrawn. The 
recipient blastocysts are picked up in a small volume of culture medium in a finely drawn pipette. 
The pipette is inserted through the uterine wall and the blastocysts and medium are gently forced 
into the uterine lumen by air pressure created by blowing on a tube connected to the pipette. 4-8 
blastocysts are placed in the uterine lumen of each foster mother. The incision is closed and the 
female placed in a cage alone until the young are born. 
Assessing Results.  The results of the cell transfers were determined in four ways. First, the ani- 
mals born to the foster mothers were observed for pigmentation of eye or coat color. The recipient 
blastocysts were always albino and both types of cells (CBA T6T6 and 129 SvS1) came from agouti 
animals. Second, lymphocyte cultures were prepared according to the technique described by Hayry 
et al.  (9)  from the blood of the animals resulting from blastocysts that received CBA T6T6  bone 
marrow cells. Chromosome preparations were made from these cultures and examined for the T6 
chromosome. Third, the offspring resulting from blastocysts into which cells were transferred were 
placed with albino animals of opposite sex for mating. The young from these matings were examined 
to determine if any germ cells contained agouti genotype from the transferred cells. Fourth, skin 
grafts were placed according to the technique described by Billingham (1) on the young resulting from 
1Abbreviation  used in this paper." EBMS, Eagle's basal medium supplemented with 5 ×  10-' M 
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the blastocysts which received bone marrow cells or teratocarcinoma cells. The survival time of these 
skin grafts was compared to the survival time of similar grafts placed on animals from the same strain 
as those supplying the recipient blastocysts (ICR Swiss albino males or females). Medium survival 
times, 95% confidence limits, and statistical significance were determined according to the methods 
described by Litchfield (10,  11). 
Results 
The first group of experiments involved transfer of CBA T6T6 bone marrow cells 
into  blastocysts from  Swiss  albino  mice.  From  these  recipient  blastocysts  77 
offspring were reared to adults. 40 were males and 37 were females. None of the 
animals  showed any pigmentation.  Chromosome preparations  were made from 
peripheral  blood  lymphocytes  of 37 ;males  and  18  females.  None  showed  T6 
chromosomes. 
However, when CBA T6T6 skin was grafted to these 77 animals,  there was a 
significant  increase  in  survival  time  of  the  grafts  on  experimental  animals 
compared  to  controls.  These  results  are  shown  in  Table  I.  The  graft  median 
survival time for male experimental mice was 10.8 days which was significantly 
greater  than  for  male  controls,  and  the  median  survival  time  for  female 
experimental  mice was  10.6 days which was also significantly  greater than  for 
female controls. The graft median survival time on male and female experimen- 
tal animals was not significantly different. 
The  distribution  of graft  survival  time  for  experimental  animals  was quite 
skewed. 40 animals rejected the grafts between day 7 and  10; 21-rejected grafts 
between day  11  and  20;,and  14  rejected  grafts  between day  21  and  30.  The 
remaining  two  grafts  remained  for  considerably  longer.  One  graft  on  a  male 
lasted for 55 days and one graft on a female lasted for 65 days. On skin grafts that 
TABLE  I 
Effect of Cells Transferred into Mouse Blastocysts on the Immune Response of Offspring 
Resulting from  the Recipient Blastocysts 
Cell type transferred 
Skin graft median survival time 
Males  Females 
Bone marrow cells  10.8 [9.1-12.8]  10.6 [8.6-13.0] 
(40)  (37) 
None (control animals)  7.4 [6.8-8.1]  8.0 [7.3-8.8] 
(40)  (37) 
Teratocarcinoma cells  11.0 [9.6-12.6]  8.9 [8.1-9.7] 
(30)  (30) 
None (control animals)  6.8 [6.0-7.7]  7.8 [7.3-8.3] 
(30)  (30) 
Median survival time is given in days and is followed by the 95% confidence limits enclosed in 
brackets. The  number of animals in each group is shown in parentheses. The significance of the 
difference between median survival times was calculated by the method of Litchfield (10, 11). The 
increase in median survival time was significant at the P  <: 0.05 level for all groups that had received 
cells. The difference between males and females was significant only for the animals that received 
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remained  in  place  for  longer  than  3  wk,  a  substantial  growth  of agouti  hair 
occurred. Fig. 1 shows the appearance at 1 mo of one of these longer-lasting grafts 
that grew hair. 
The  second group of experiments involved transfer of teratocarcinoma cells 
from 129 SvS1 (agouti) mice into blastocysts from Swiss albino mice. From these 
recipient blastocysts, 60 offspring were reared to adults. 30 were males and 30 
were females. One of the males had several small patches or stripes of agouti hair. 
Fig. 2 shows the extent of these agouti areas. The areas resembled thin stripes of 
hair running from the dorsal midline laterally on the right thorax and flank. They 
did not extend across the dorsal midline or on to the belly hair. The pattern was 
similar to that seen in some animals resulting from whole embryo fusion (13). 
There was also a small area of agouti hair immediately anterior to the base of the 
left ear.  This male was mated to numerous females but no offspring resulted. 
Skin from a  129 SvS1 male was grafted on this male. The first graft was torn off 
by the animal shortly after the protective cast was removed. The second graft 
remained for 26 days before it was off. 
Skin grafts were made on all 60 of the animals resulting from the blastocysts 
that received 129 SvS1 cells, and there was a significant increase in survival time 
of these grafts when compared to those made on control animals. These results 
are shown in Table I. The graft median survival time for experimental males and 
females was 11.0 and 8.9 days respectively. Both these values are significantly 
greater than the corresponding controls. In addition, the graft median survival 
time on the males was 2.1 days longer than on the females. This difference was 
significant, but the difference in graft median survival time for the controls was 
not significant. 
The  distribution of graft survival time for  the  animals from the teratocar- 
cinoma cell transfers was skewed in a manner similar to that found for animals 
from the CBA T6T6 cell transfers. 36 rejections occurred between 7 and 10 days; 
21 between 11 and 20 days; and 3 after 20 days. 
All of the animals resulting from the bone marrow cells transfers and those 
from  the  teratocarcinoma  cell  transfers  were  placed  with  albino  mice  to 
determine if there were any germ cells with agouti genotype. No agouti young 
resulted from these matings. 
Discussion 
The results of the experiments in which CBA T6T6 cells were transferred into 
blastocysts provide  evidence  that  some  cells  taken  from  the  adult  body are 
capable of participating in development of the embryo. The absence of evidence 
for the presence of the transferred cells in the pigmented tissues of the adults, in 
the germ cells, and in the peripheral lymphocytes suggests strongly that the cells 
did not clone the embryo to a large extent in these experiments. However, in the 
studies with peripheral lymphocytes one cannot rule out the possibility that a 
very few T6T6 cells were present among the lymphocytes. All that can be said is 
that  of  the  approximately  2,000  chromosome  spreads  examined  from  these R,  L.  BRINSTER  1053 
FIG. 1.  A random-bred Swiss albino mouse with a CBA T6T6 skin graft. The graft is 24 days 
old and has grown agouti hair. The animal developed from a blastocyst of Swiss albino geno- 
type that received CBA T6T6 bone marrow cells. 
FIG.  2.  A  random-bred  Swiss  albino  mouse  with  several  stripes of agouti  hair  extending 
from the midline over the right flank and thorax. An additional group of agouti hairs is present 
at the anterior base of the left ear. The animal developed from a blastocyst of Swiss albino 
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animals, none contained T6 chromosomes. Perhaps the cloning efficiency is much 
lower than this under the conditions of these experiments. 
The skin graft results from these animals, however, clearly indicate an effect of 
the  transferred bone  marrow  cells.  It  seems  very unlikely that such a  strong 
immunological effect in the  adult could result from the presence  of the  CBA 
antigens in the embryo from only a short time following the transfer of the cells. 
The highly significant prolongation of skin graft survival time in these animals 
seems  more  likely to  result  from  the  colonization of the  embryo by  a  small 
number of cells for an extended period. A few CBA cells may still exist in those 
adults where the grafts were maintained for a week or more longer than controls. 
The results of the experiments in which 129  SvSI teratocarcinoma cells were 
transferred into blastocysts provide evidence that this type of malignant cell is 
capable  of  participating  in  development  of  the  embryo.  In  addition,  the 
experiments indicate that the embryo environment can bring under control the 
autonomous proliferation of the teratocarcinoma cells.  The  interaction of the 
teratocarcinoma cells with embryo cells must be quite different than with adult 
cells,  since  in  the  adult the  cells  generally result  in  death  of the  animal  in 
approximately 3 wk. 
The appearance of the agouti hairs in one of the offspring resulting from the 129 
SvS1  cell  transfers  provides  very strong  evidence for the  participation of the 
transferred cells in embryo development. Although the number of hairs is small, 
they are  unequivocably present and  could not arise from the albino recipient 
blastocyst genotype. The inability of the animal to maintain a  129  SvS1 skin 
graft indefinitely could have been due to the type of cell or small number of cells 
present. These may not have created sufficient tolerance to maintain a skin graft. 
A number of situations have been described in which chimerism exists without 
skin graft tolerance (2). 
The skin graft data from the animals that received the teratocarcinoma cell 
transfers provide  additional and  convincing evidence for the  participation  in 
embryo development and for the presence  in the adult of 129  SvS1 cells. The 
reason for the 2.1  day difference in graft survival time between the males and 
females is not readily apparent. A possible explanation may be related to the sex 
genotype of the transferred cells. In the CBA cell transfers, the bone marrow cells 
came  randomly from  males  and  females and  were  placed  into blastocysts of 
unknown sex,  presumably random or half male and half female. However, the 
teratocarcinoma cells used in these studies came from a testicular teratoma (17, 
18), and therefore all carried the Y chromosome. Perhaps it is more difficult for a 
cell with a  Y chromosome to establish a  colony in a female embryo because of 
antigens associated with Y chromosome expression. This could explain why the 
cloning of the females was less efficient than the cloning of the males by the male 
genotype teratocarcinoma cells. A similar effect in the CBA cell transfers might 
not be observed because the random combinations between transferred cells and 
blastocysts would decrease the differences. In addition the CBA strain may not 
react as strongly to the male antigen as does the 129 strain. Differences between 
strains in responsiveness to Y antigen have been demonstrated (16). However, in 
general the Y antigen has a weak effect (7), and the difference in median survival 
time between the male and female groups may result from other causes. R.  L. BRINSTER  1055 
Summary 
Bone marrow cells from CBA T6T6 mice and testicular teratocarcinoma cells 
from  129  SvS1  mice were  transferred  into blastocysts  from random-bred  Swiss 
albino mice. The blastocysts were allowed to develop in foster mothers and the 
adults  resulting from these blastocysts were studied  for evidence of an effect of 
the transferred cells. A total of 137 adults resulted from the experiments, and one 
of  the  mice  that  had  received  teratocarcinoma  cells  in  the  blastocyst  stage 
showed several thin stripes of agouti hair. All the adult animals received grafts of 
skin from animals identical to those supplying the cells. In all cases the animals 
that resulted from blastocysts into which cells had been transferred maintained 
skin grafts for a significantly longer period than controls. In a number of cases the 
graft  developed  agouti  hair  and  in  two  cases  the  graft  was  maintained  for 
approximately 2  mo. These experiments indicate that the transferred cells were 
able  to  establish  small  colonies  in  the  embryos  and  that  some  of these  cells 
persisted into the adult. 
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